Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Bionect, 0.2% hyaluronic acid
print preview
bookmark
share with colleague
General Information
Company
Innocutis Holdings LLC
Description
Low moleuclar weight formulation of hyaluronic acid
Molecular Target
Mechanism of Action
Latest Stage of Development
Marketed
Indication
Dermatosis
Partner
Dara BioSciences Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information